Concepedia

Author

Kai Hung Tiong

International Medical University

Also Known As

K H Tiong, K.H. Tiong, Kai Hung Tiong, Tiong, Kai

38

Publications

948

Citations

13

H-Index

31

Concepts

All Affiliations

International Medical UniversityInstitute for Medical ResearchUniversity of MalayaCancer Research MalaysiaMonash University Malaysia
KH

About

Kai Hung Tiong is an author at International Medical University specializing in medicine, tumor biology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

436

2

Cell Biology

5

5

293

3

Biochemistry

4

4

118

4

Natural Sciences

2

2

87

5

Engineering

1

1

60

Kai Hung Tiong

×

15

Publications

769

Citations

12

H-Index

YearCitations

Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF)

Boon Shing Tan, Kai Hung Tiong, Heng Lungh Choo,

Cell Death and Disease

2015

146

6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ)

Boon Shing Tan, Owen Kang, Chun‐Wai Mai,

Cancer Letters

2013

93

Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73

Su Wei Wong, Kai Hung Tiong, Weng Yip Kong,

Breast Cancer Research and Treatment

2010

82

Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival

Kai Hung Tiong, Boon Shing Tan, Heng Lungh Choo,

Oncotarget

2016

78

CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells

Boon Shing Tan, Kai Hung Tiong, Ashwin Muruhadas,

Molecular Cancer Therapeutics

2011

68

DeSigN: connecting gene expression with therapeutics for drug repurposing and development

Bernard Kok Bang Lee, Kai Hung Tiong, Jit Chang,

BMC Genomics

2017

68

Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies

Muhammad Zaki Hidayatullah Fadlullah, Ivy Kim-Ni Chiang, Kalen R. Dionne,

Oncotarget

2016

60

Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells

Soon Yang Low, Boon Shing Tan, Heng Lungh Choo,

Cancer Letters

2011

42

Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells

Nur Syafinaz Zainal, Chai Phei Gan, Beng Fye Lau,

Phytomedicine

2017

41

<i>In vitro</i>modulation of naturally occurring flavonoids on cytochrome P450 2A6 (CYP2A6) activity

Kai Hung Tiong, Beow Chin Yiap, Eng Lai Tan,

Xenobiotica

2010

20

Page 1